Phase I dose-escalation study evaluating the safety and efficacy of Multikine in HIV-infected patients with HPV-induced cervical dysplasia

Trial Profile

Phase I dose-escalation study evaluating the safety and efficacy of Multikine in HIV-infected patients with HPV-induced cervical dysplasia

Discontinued
Phase of Trial: Phase I

Latest Information Update: 23 Oct 2013

At a glance

  • Drugs Buffy coat interleukins (Primary)
  • Indications Cervical cancer; Cervical dysplasia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Oct 2013 New trial record
    • 07 Oct 2013 This study had been approved by the Human Subjects Institutional Review Board, according to a CEL-SCI Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top